AxoGen Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.69
Market Cap
$779.79 M
Shares Outstanding
39.21 M
Public Float
34.88 M

Profile

Address
13631 Progress Boulevard
Alachua Florida 32615
United States
Employees -
Website http://www.axogeninc.com
Updated 07/08/2019
AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provide products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator.

Financials

View All

Karen L. Zaderej
Chairman, President & Chief Executive Officer
Amy Wendell
Lead Director